✦ LIBER ✦

PMS31 THE IMPACT OF CHANGES IN ADALIMUMAB, ETANERCEPT, AND INFLIXIMAB DOSES ON THE COSTS OF TREATING RHEUMATOID ARTHRITIS

✍ Scribed by RW Lawson; RM Heatley; KI Johnson; RK Khandker; A Singh

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

PMS19 COST MINIMIZATION AND BUDGET IMPAC

✍ MG Saggia; EA Santos; V Nasciben 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 73 KB

PMS15 COST-EFFECTIVENESS OF THE TREATMEN

✍ E Mucino; R Rivas; L Zapata 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 67 KB

PMS49 Cost-Effectiveness Analysis of Eta

✍ P. Guijarro; C. Crespo; M. Brosa 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 61 KB

PMS31 AN EVENT-LEVEL ANALYSIS OF PRESCRI

✍ J Rizzo; C Gunnarsson; H Fang; C Carter; S Bolge; RS McKenzie 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 76 KB

Efficacy of treatment intensification wi

✍ Eng, Grith; Stoltenberg, Michael B.; Szkudlarek, Marcin; Bouchelouche, Pierre N. 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 286 KB

PMS22 ADALIMUMAB, ETANERCEPT AND INFLIXI

✍ T Macioch; M Niewada; W Wrona; D Golicki; T Hermanowski 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 72 KB